Nicola Potter

11PUBLICATIONS
60CO-AUTHORS
Medical virologyMedical infection agents (incl. prions)Medical mycologyPredictive and prognostic markersTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 04, 2026
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.

|Sep 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Nigel Russell, Jad Othman, Oliver Cumming

|Aug 06, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.

Jad Othman, Nicola Potter, Sylvie D Freeman

|Sep 24, 2024
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Sun Loo, Nicola Potter, Adam Ivey

|Sep 16, 2024
Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML.

Liesbeth Vanheeswijck, Sanjay Tewari, Robin Dowse

|May 23, 2024
Recommendations from the AML molecular MRD expert advisory board.

Stuart Scott, Alison Devonshire, Richard Dillon

Pageof 2

Frequent Collaborators

9 joint publications

Jad Othman

5 joint publications

Sylvie D Freeman

5 joint publications

Richard Dillon

4 joint publications

Ing Soo Tiong